EMEA-001418-PIP01-13-M05

Table of contents

Key facts

Invented name
Vocabria
Active substance
Cabotegravir
Therapeutic area
Infectious diseases
Decision number
P/0396/2022
PIP number
EMEA-001418-PIP01-13-M05
Pharmaceutical form(s)
  • Age-appropriate oral dosage form
  • Film-coated tablet
  • Prolonged-release suspension for injection
Condition(s) / indication(s)
Treatment of human immunodeficiency virus (HIV-1) infection
Route(s) of administration
  • Intramuscular use
  • Oral use
Contact for public enquiries
ViiV Healthcare UK Limited

E-mail: eu.paediatric-plans@gsk.com
Tel.: +44 (0)2089903650

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating